We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEON icon
13351
CALL
VEON
VEON
$3.93B
$31K ﹤0.01%
736
+100
+16% +$4.88K
SEEL
13352
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$31K ﹤0.01%
5
-13
-72% -$99.8K
KA
13353
PUT
DELISTED
Kineta, Inc. Common Stock
KA
$31K ﹤0.01%
+1,500
New +$64.9K
ARAV
13354
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$31K ﹤0.01%
14,000
-40,100
-74% -$133K
LMDXW
13355
DELISTED
LumiraDx Limited Warrant
LMDXW
$31K ﹤0.01%
21,431
-314
-1% -$507
CRXT
13356
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$31K ﹤0.01%
+12,597
New +$54.7K
CBUS icon
13357
PUT
Cibus
CBUS
$135M
$30K ﹤0.01%
+286
New +$41.5K
FTK icon
13358
Flotek Industries
FTK
$1.3B
$30K ﹤0.01%
+4,495
New +$25.5K
HYMC icon
13359
Hycroft Mining Holding Corp
HYMC
$2.52B
$30K ﹤0.01%
4,929
+2,742
+125% +$31.2K
ICUCW
13360
SeaStar Medical Holding Corp Warrant
ICUCW
$339K
$30K ﹤0.01%
65,438
+101
+0.2% +$50
TRX icon
13361
CALL
TRX Gold Corp
TRX
$367M
$30K ﹤0.01%
76,500
-3,200
-4% -$1.39K
SGTX
13362
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$30K ﹤0.01%
+838
New +$47.7K
RAAS
13363
PUT
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$30K ﹤0.01%
3,400
-8,933
-72% -$101K
ODT
13364
PUT
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$30K ﹤0.01%
22,400
-11,500
-34% -$27.2K
CEMI
13365
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$30K ﹤0.01%
25,900
-27,700
-52% -$56.4K
GYRE icon
13366
Gyre Therapeutics
GYRE
$708M
$29K ﹤0.01%
4,202
-4,519
-52% -$77.3K
IBIO icon
13367
PUT
iBio
IBIO
$71M
$29K ﹤0.01%
107
-113
-51% -$43.1K
KRKR
13368
36Kr Holdings
KRKR
$5.92M
$29K ﹤0.01%
1,365
+326
+31% +$9.56K
PHIO icon
13369
Phio Pharmaceuticals
PHIO
$12.7M
$29K ﹤0.01%
269
+18
+7% +$2.86K
PLUR icon
13370
Pluri
PLUR
$17.3M
$29K ﹤0.01%
2,462
-4,800
-66% -$94.9K
UAMY icon
13371
CALL
United States Antimony
UAMY
$825M
$29K ﹤0.01%
58,100
-5,300
-8% -$3.9K
PHLT
13372
CALL
DELISTED
Performant Healthcare Inc
PHLT
$29K ﹤0.01%
+11,900
New +$35.4K
VINO
13373
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$29K ﹤0.01%
11
-2
-15% -$6.88K
ATNX
13374
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
$29K ﹤0.01%
1,070
-1,365
-56% -$57.6K
GLDG
13375
GoldMining Inc
GLDG
$226M
$28K ﹤0.01%
22,860
-23,332
-51% -$30.3K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.